Article
Increased prevalence of pretreatment drug resistance mutations in treatment-naïve people living with HIV-1 in Henan Province, China (2022/23).
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases - 1 Nov 2023
Liu Jinjin, Liu Chunli, Wang Yanli, Wei Shuguang, Ma Jie, Li Yuanyuan, Chen Xuhui, Zhao Qingxia, Huo Yuqi
Abstract excerpt
Human deficiency virus type 1 (HIV-1) harboring drug resistance mutations (DRMs) before the initiation of antiretroviral therapy (ART) poses a serious threat to the efficacy of current ART regimens. Currently, the prevalence of pre-treatment drug resistance mutations (PDRMs) including transmitted DRMs (TDRMs) is not completely clear. Understanding this prevalence better should offer valuable data for clinical-...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.